Oct
2026
Fiera Milano, Italy
Visit us
stand 2H42, API

Pen Tsao Chemical Industry Ltd

Exhibitor at CPHI Milan 2026
About Us

PEN TSAO GROUP with headquarter in Hong Kong, development and production sites in Shanghai (PTCI SH; API’s and Intermediates) and Dushan Port, Zhejiang Province (RODALLIS Biopharma; API’s, Intermediates and OSD Formulation) is a renowned specialty pharma company and a reliable partner with high quality awareness, state of the art technology and highly skilled personnel, delivering added value products and services to its clients. RODALLIS Biopharma will essentially expand our capabilities for CMO projects and API production; the OSD Formulation...

  • Country/Region:
    Hong Kong
  • On CPHI since:
    2015
  • Certificates:
    2
  • Employees:
    100 - 249
Company types
Biopharmaceutical company
CMO/CDMO
Other
Pharmaceutical company
Primary activities
Custom Manufacturing/Custom Synthesis
Generic APIs producer
Pharmaceutical Company (generic finished products)
Contact info
Event information
CPHI Milan 2026
  • 6 Oct 2026 - 8 Oct 2026
  • Fiera Milano, Italy
  • Visit us at stand 2H42, API

Products Featured at CPHI Milan 2026

  • Loxoprofen Sodium

    Product Loxoprofen Sodium

    Loxoprofen Sodium sold mainly as Loxoprofen Sodium Dihydrate (CAS:226721-96-6).  Registration in Japan, Korea, China. Specifications: JP, KP, CP, In-house
  • Ethionamide

    Product Ethionamide

    Ethionamide belongs to the secondary MDR Anti-TB drugs used in the fight against Tuberculosis. WHO prequalified API since 2013. Registrations in India, Russia, Ukraine. Specifications: EP, EPW, IP, USP, In-house. 
  • Bucillamine

    Product Bucillamine

    Bucillamine is an antirheumatic agent.  It is mainly used in Japan and Korea. Activity is mediated by the two thiol groups that the molecule contains. Research done in USA showed positive transplant preservation properties. Bucillamine has been used in trials studying the...
  • Clofazimine

    Product Clofazimine

    Clofazimine is a phenazine dye with anti-mycobacterial and anti-inflammatory activities.Clofazimine is used to treat Leprosis and is active against various other Mycobacteria. WHO recommends its for the treatment of MDR & XDR Tuberculosis. WHO Prequalification in progress. Specifications: EP,...
  • Prothionamide

    Product Prothionamide

    Protionamide is a thioamide derivative with antitubercular activity, belongs to the secondary MDR Anti-TB drugs used in the fight against Tuberculosis. WHO prequalified API since 2013. Registrations in China, India, Germany, Ukraine. Specifications: BP, BPD, BPD-W, CP, IP, In-house.  

Pen Tsao Chemical Industry Ltd Resources (1)

  • Brochure Rodallis Biopharma Co. Ltd.

    Pen Tsao's new API Production and OSD Formulation located in Pinghu City around 100 km sout of our existing manufacturing base in Shanghai is progressing and start of commercial production is scheduled for Mid 2026. Visit our website www.rodallis.com